RAD23BP2

Across TCGA pan-cancer cohorts, RAD23BP2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RAD23BP2 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RAD23BP2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RAD23BP2 expression acts as an unfavorable survival marker, although some lineages such as LAML and HNSC show a favorable association.

READ, KIRP, and BRCA are the cancer types where RAD23BP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	II,III,IV	0.166	0.691	<.001	108	view →
KIRP	OS	Tertile	All	0.531	0.893	<.001	90	view →
BRCA	OS	Tertile	All	0.385	0.585	<.001	72	view →
LUSC	DFS	Tertile	All	0.486	0.807	<.001	63	view →
THCA	DFS	Tertile	All	0.553	0.839	<.001	63	view →
STAD	OS	Quartile	All	0.277	0.572	.013	42	view →
LAML	DFS	Tertile	All	0.794	0.503	.013	24	view →
ESCA	DFS	Tertile	All	0.152	0.708	.011	18	view →
COAD	DFS	Tertile	II,III,IV	0.132	0.553	.004	15	view →
HNSC	DFS	Tertile	III,IV	0.845	0.256	.043	12	view →
LGG	DFS	Tertile	All	0.686	0.837	.026	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RAD23BP2–READ (OS)

Open the READ breakdown →